|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 81.29 USD | +0.89% |
|
+2.57% | -1.32% |
| 05:25pm | Edwards Lifesciences Corporation: The story continues |  |
| Apr. 17 | Baird Adjusts Medtronic Price Target to $88 From $91 | MT |
By Denny Jacob
Medtronic PLC said Friday that it received approval from the U.S. Food and Drug Administration for the Onyx Frontier drug-eluting stent.
The medical-technology company said the stent is used for the treatment of patients with coronary-artery disease.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
05-13-22 0831ET
| 1st Jan change | Capi. | |
|---|---|---|
| -1.32% | 107B | |
| -2.25% | 186B | |
| -3.92% | 67.57B | |
| +7.99% | 50.7B | |
| +15.74% | 47.2B | |
| -0.45% | 39.72B | |
| +10.81% | 27.48B | |
| +2.34% | 25.65B | |
| +13.37% | 24.97B | |
| -0.16% | 24.82B |
MEDTRONIC PLC 
